M. Lytken Larsen

The quality needed for measuring glycated haemoglobin. An application.

C. Fraser, P. Hyltoft Petersen, M. Lytken Larsen, 1990, Upsala journal of medical sciences.

Non-Persistence with Medication as a Mediator for the Social Inequality in Risk of Major Adverse Cardiovascular Events in Patients with Incident Acute Coronary Syndrome: A Nationwide Cohort Study

S. Riahi, T. Holmberg, S. Paaske Johnsen, 2021, Clinical epidemiology.

Analytical goal setting prior to selection of a method for glycated haemoglobin.

M. Hørder, O. Blaabjerg, P. Hyltoft Petersen, 1990, Scandinavian journal of clinical and laboratory investigation.

Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL)

O. Faergeman, I. Holme, J. Kastelein, 2008, Annals of medicine.

Trends in low-density lipoprotein cholesterol goal achievement and changes in lipid-lowering therapy after incident atherosclerotic cardiovascular disease: Danish cohort study

A. Green, A. Ersbøll, M. Nybo, 2023, PloS one.